BALCHEM CORPBCPC财报
Balchem Corp is a global specialty chemicals and nutritional ingredients provider that develops, manufactures and distributes application-specific products for human nutrition, animal health, pharmaceutical and industrial end markets, serving customers across North America, Europe and Asia Pacific.
BCPC Q4 2025 Key Financial Metrics
营收
$263.6M
毛利润
$93.9M
营业利润
$52.3M
净利润
$39.2M
毛利率
35.6%
营业利润率
19.8%
净利率
14.9%
同比增长
9.8%
EPS
$1.21
资金流向
BALCHEM CORP Q4 2025 财务摘要
BALCHEM CORP reported revenue of $263.6M (up 9.8% YoY) for Q4 2025, with a net profit of $39.2M (up 16.8% YoY) (14.9% margin). Cost of goods sold was $169.7M, operating expenses totaled $41.6M.
核心财务指标
| 总营收 | $263.6M |
|---|---|
| 净利润 | $39.2M |
| 毛利率 | 35.6% |
| 营业利润率 | 19.8% |
| 报告期 | Q4 2025 |
营收拆解
BALCHEM CORP Q4 2025 revenue of $263.6M breaks down across 3 segments, led by Human Nutrition And Health at $166.1M (63.0% of total).
| 业务分部 | 营收 | 占比 |
|---|---|---|
| Human Nutrition And Health | $166.1M | 63.0% |
| Animal Nutrition And Health | $61.2M | 23.2% |
| Specialty Products | $34.8M | 13.2% |
BALCHEM CORP 分部营收 — 季度趋势
BALCHEM CORP revenue by segment across the last 4 reported quarters, showing how each business line (such as Human Nutrition And Health and Animal Nutrition And Health) has evolved quarter over quarter.
| 业务分部 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|
| Human Nutrition And Health | $166.1M | $174.1M | $160.8M | $158.5M |
| Animal Nutrition And Health | $61.2M | $56.4M | $56.0M | $57.3M |
| Specialty Products | $34.8M | $35.7M | $37.2M | $33.3M |
BALCHEM CORP 年度营收
BALCHEM CORP annual revenue history includes year-by-year totals (for example, 2025 revenue was $1.0B). Click any linked year to see what changed vs the prior 10-K.
BALCHEM CORP 季度营收与净利润历史
BALCHEM CORP quarterly results over the last 8 reported quarters, including revenue, net profit and year-over-year growth.
| 季度 | 营收 | 营收同比 | 净利润 | 净利率 |
|---|---|---|---|---|
| Q4 2025 | $263.6M | +9.8% | $39.2M | 14.9% |
| Q3 2025 | $267.6M | +11.5% | $40.3M | 15.1% |
| Q2 2025 | $255.5M | +9.1% | $38.3M | 15.0% |
| Q1 2025 | $250.5M | +4.5% | $37.1M | 14.8% |
| Q4 2024 | $240.0M | +4.9% | $33.6M | 14.0% |
| Q3 2024 | $239.9M | +4.3% | $33.8M | 14.1% |
| Q2 2024 | $234.1M | +1.2% | $32.1M | 13.7% |
| Q1 2024 | $239.7M | +3.1% | $29.0M | 12.1% |
利润表
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| 营收 | $239.7M | $234.1M | $239.9M | $240.0M | $250.5M | $255.5M | $267.6M | $263.6M |
| 同比增长 | 3.1% | 1.2% | 4.3% | 4.9% | 4.5% | 9.1% | 11.5% | 9.8% |
资产负债表
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| 总资产 | $1.59B | $1.57B | $1.60B | $1.58B | $1.62B | $1.68B | $1.66B | $1.69B |
| 总负债 | $509.9M | $462.6M | $419.7M | $425.5M | $408.9M | $410.3M | $363.2M | $428.8M |
| 股东权益 | $1.08B | $1.11B | $1.18B | $1.15B | $1.21B | $1.27B | $1.30B | $1.26B |
现金流量表
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| 经营性现金流 | $33.4M | $45.0M | $51.3M | $52.3M | $36.5M | $47.3M | $65.6M | $67.3M |